{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:21:10Z","timestamp":1783095670808,"version":"3.54.6"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.parkreldis.2026.108359","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:33:28Z","timestamp":1779147208000},"page":"108359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chorioretinal structural and microvascular alterations as biomarkers for the diagnosis of Parkinson's disease"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8190-7277","authenticated-orcid":false,"given":"Alaa Din","family":"Abdin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Aljundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Kaymak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Fa\u00dfbender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinzenz","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Schr\u00f6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Gonzalez-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Ulrich","family":"Dillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Groppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.parkreldis.2026.108359_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1871527322666230330093829","article-title":"Blood\u2013brain barrier and neurovascular unit dysfunction in Parkinson's disease: from clinical insights to pathogenic mechanisms and novel therapeutic approaches","volume":"23","author":"Khor","year":"2024","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"issue":"7","key":"10.1016\/j.parkreldis.2026.108359_bib2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations","volume":"18","year":"2003","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108359_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamaophthalmol.2020.5730","article-title":"Characterization of retinal microvascular and choroidal structural changes in Parkinson disease","volume":"139","author":"Robbins","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.parkreldis.2026.108359_bib4","article-title":"Retinal microvascular density is associated with clinical progression of Parkinson's disease","volume":"14","author":"Xu","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108359_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jnnp-2022-329342","article-title":"Structural and functional changes in the retina in Parkinson's disease","volume":"94","author":"Alves","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108359_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3233\/JPD-140454","article-title":"String vessel formation is increased in the brain of Parkinson disease","volume":"5","author":"Yang","year":"2015","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108359_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood\u2013brain barrier permeability in Parkinson's disease","volume":"35","author":"Gray","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.parkreldis.2026.108359_bib8","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41598-020-80889-8","article-title":"Human \u03b1-synuclein overexpression leads to vascular pathology and blood\u2013brain barrier leakage","volume":"11","author":"Elabi","year":"2021","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.parkreldis.2026.108359_bib9","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/s41433-023-02483-2","article-title":"Optical coherence tomography angiography in Parkinson's disease: a systematic review and meta-analysis","volume":"37","author":"Salehi","year":"2023","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.parkreldis.2026.108359_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123294","article-title":"Choroidal thickness in Parkinson's disese: a systematic review and meta-analysis","volume":"467","author":"Fekrazad","year":"2024","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108359_bib11","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1111\/aos.12809","article-title":"The choroid and lamina cribrosa are affected in Parkinson's disease","volume":"94","author":"Eraslan","year":"2016","journal-title":"Acta Ophthalmol."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108359_bib12","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3233\/JPD-212676","article-title":"Choroidal thickness correlates with clinical and imaging metrics of Parkinson's disease","volume":"11","author":"Brown","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108359_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/bjophthalmol-2013-304587","article-title":"Ophthalmic statistics note 1: unit of analysis","volume":"98","author":"Bunce C","year":"2014","journal-title":"Br. J. Ophthalmol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026001860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026001860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:43:20Z","timestamp":1783093400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026001860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":13,"alternative-id":["S1353802026001860"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108359","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chorioretinal structural and microvascular alterations as biomarkers for the diagnosis of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108359"}}